Phenazopyridine Hydrochloride

Phase 3Small molecule

AAmneal Pharmaceuticals, LLC

Phenazopyridine Hydrochloride is one of 37 small molecule programs targeting Effectiveness. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

EffectivenessRecruiting

EffectivenessPhase 3

Recruiting

Competition

Competitive Landscape

73 competitors in Effectiveness

#DrugCompanyPhaseTrials

Kesimpta

Novartis

Phase 3

2 2

Mounjaro

Eli Lilly

Phase 3

1 3

Actos

Takeda

Phase 3

1 4

Nicotine Free Cigarettes

Pfizer

Phase 3

3 5

Botulinum Toxin a

GSK

Phase 3

1 6

Gemzar

Johnson & Johnson

Phase 2

1 7

Temodar

CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Phase 2

1 8

Haldol

DDePuy Orthopaedics

Phase 2

1 9

Welireg

CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Phase 2

1 10

Pneumococcal Conjugate Vaccine

Novartis

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Safety and Efficacy1 trial

Evaluate the Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg vs. Placebo

Completed·AAmneal Pharmaceuticals, LLC·Phase 3·NCT01064024·233 enrolled

Urinary Tract Infection1 trial

Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg as an Analgesic for Short-Term Treatment in Female Subjects Suffering From Moderate-to-Severe Pain and Burning Upon Urination Associated With Uncomplicated Urinary Tract Infections (uUTI)

Completed·AAmneal Pharmaceuticals, LLC·Phase 3·NCT01650051·424 enrolled

Effectiveness1 trial

Effectiveness of Phenazopyridine for Pain Following Urodynamics

Recruiting·UUniversity of South Florida·Phase 4·NCT06577493·66 enrolled

Cognitive impairment1 trial

Effects of Methylene Blue in Healthy Aging, Mild Cognitive Impairment and Alzheimer's Disease

Completed·TThe University of Texas Health Science Center at San Antonio·Phase 2·NCT02380573·117 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for Phenazopyridine Hydrochloride. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Phenazopyridine Hydrochloride compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Phenazopyridine Hydrochloride. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Amneal Pharmaceuticals, LLC company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: AAmneal Pharmaceuticals, LLC

Phenazopyridine Hydrochloride

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Safety and Efficacy1 trial

Urinary Tract Infection1 trial

Effectiveness1 trial

Cognitive impairment1 trial

References

Drug Info

Quick Facts

Related News